BetterLife Pharma (CSE: BETR) CEO Dr. Ahmad Doroudian and Amanda Siebert, Reporter for Forbes & The Dales Report, joined Steve Darling from Proactive in the first episode of our series “The Business of Psychedelics”. In the first episode, both Doroudian and Siebert shared their thoughts on the psychedelic industry and at what point they feel this emerging industry is at. Siebert also shared with Proactive her thoughts on big pharma looking to participate in the industry.
Betterlife Pharma The Business of Psychedelics: Episode 1
